555.26MMarket Cap-3729P/E (TTM)
8.600High7.950Low585.60KVolume8.210Open7.980Pre Close4.87MTurnover2.23%Turnover RatioLossP/E (Static)67.06MShares11.55052wk High2.50P/B217.26MFloat Cap2.35052wk Low--Dividend TTM26.24MShs Float29.690Historical High--Div YieldTTM8.15%Amplitude2.210Historical Low8.316Avg Price1Lot Size
Eliem Therapeutics Stock Forum
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
Eliem Therapeutics has completed its acquisition of Tenet Medicines and a concurrent $120 million private placement. The company plans to advance TNT119, an anti-CD19 antibody aimed at treating various autoimmune diseases, including systemic lupus erythematosus, immune thrombocytopenia, and membranous nephropathy. With the acquisition, Eli...
Onconova Tx merger w/ Trawsfynydd Tx
$Aditxt (ADTX.US)$ to acquire Appili Tx
TuHURA Biosciences merger w/ $Kintara Therapeutics (KTRA.US)$
$Johnson & Johnson (JNJ.US)$ to acquire $ShockWave Medical (SWAV.US)$
$Vertex Pharmaceuticals (VRTX.US)$ to acquire $Alpine Immune (ALPN.US)$
$Century Therapeutics (IPSC.US)$ to acquire Clade Tx
$Eliem Therapeutics (ELYM.US)$ to acquire Tenet Med.
$Incyte (INCY.US)$ to acquire Escient Pharm.
ONO Pharm to acquire $Deciphera Pharmaceuticals (DCPH.US)$